{"id":"https://openalex.org/W2886679183","doi":"https://doi.org/10.1002/jcp.26851","title":"Sodium\u2013glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways","display_name":"Sodium\u2013glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways","alternate_titles":[],"publication_year":2018,"publication_date":"2018-08-04","ids":{"openalex":"https://openalex.org/W2886679183","doi":"https://doi.org/10.1002/jcp.26851","mag":"2886679183","pmid":"https://pubmed.ncbi.nlm.nih.gov/30076706"},"language":"en","primary_location":{"id":"doi:10.1002/jcp.26851","doi":"https://doi.org/10.1002/jcp.26851","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jcp.26851","pdf_url":null,"source":{"id":"https://openalex.org/S43643205","display_name":"Journal of Cellular Physiology","issn_l":"0021-9541","issn":["0021-9541","1097-4652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cellular Physiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2886679183"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030709980","display_name":"Habib Yaribeygi","orcid":"https://orcid.org/0000-0002-1706-6212","observed_orcids":["https://orcid.org/0000-0002-1706-6212"]},"institutions":[{"id":"https://openalex.org/I48379061","display_name":"Shahid Beheshti University","ror":"https://ror.org/0091vmj44","country_code":"IR","type":"education","lineage":["https://openalex.org/I48379061"]},{"id":"https://openalex.org/I58048189","display_name":"Shahid Beheshti University of Medical Sciences","ror":"https://ror.org/034m2b326","country_code":"IR","type":"education","lineage":["https://openalex.org/I58048189"]}],"countries":["IR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Habib Yaribeygi","raw_affiliation_strings":["Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"],"raw_orcid":"https://orcid.org/0000-0002-1706-6212","affiliations":[{"raw_affiliation_string":"Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran","institution_ids":["https://openalex.org/I48379061","https://openalex.org/I58048189"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023255400","display_name":"Alexandra E. Butler","orcid":"https://orcid.org/0000-0002-5762-3917","observed_orcids":["https://orcid.org/0000-0002-5762-3917"]},"institutions":[{"id":"https://openalex.org/I4210158896","display_name":"Anti-Doping Laboratory","ror":"https://ror.org/05hvam844","country_code":"QA","type":"facility","lineage":["https://openalex.org/I4210158896"]}],"countries":["QA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexandra E. Butler","raw_affiliation_strings":["Life Sciences Research Division, Anti-Doping Laboratory Qatar, Doha, Qatar"],"raw_orcid":"https://orcid.org/0000-0002-5762-3917","affiliations":[{"raw_affiliation_string":"Life Sciences Research Division, Anti-Doping Laboratory Qatar, Doha, Qatar","institution_ids":["https://openalex.org/I4210158896"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064495299","display_name":"Stephen Lawrence Atkin","orcid":"https://orcid.org/0000-0002-5887-7257","observed_orcids":["https://orcid.org/0000-0002-5887-7257"]},"institutions":[{"id":"https://openalex.org/I4210152471","display_name":"Weill Cornell Medical College in Qatar","ror":"https://ror.org/05v5hg569","country_code":"QA","type":"education","lineage":["https://openalex.org/I4210152471"]}],"countries":["QA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen L. Atkin","raw_affiliation_strings":["Weill Cornell Medicine Qatar, Doha, Qatar"],"raw_orcid":"https://orcid.org/0000-0002-5887-7257","affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine Qatar, Doha, Qatar","institution_ids":["https://openalex.org/I4210152471"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058321397","display_name":"Niki Katsiki","orcid":"https://orcid.org/0000-0003-0894-2644","observed_orcids":["https://orcid.org/0000-0003-0894-2644"]},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]},{"id":"https://openalex.org/I4210116665","display_name":"Ippokrateio General Hospital of Thessaloniki","ror":"https://ror.org/02kpyrm37","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210116665"]}],"countries":["GR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Niki Katsiki","raw_affiliation_strings":["Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece"],"raw_orcid":"https://orcid.org/0000-0003-0894-2644","affiliations":[{"raw_affiliation_string":"Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece","institution_ids":["https://openalex.org/I21370196","https://openalex.org/I4210116665"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036163332","display_name":"Amirhossein Sahebkar","orcid":"https://orcid.org/0000-0002-8656-1444","observed_orcids":["https://orcid.org/0000-0002-8656-1444"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Amirhossein Sahebkar","raw_affiliation_strings":["Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran","Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran","School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":"https://orcid.org/0000-0002-8656-1444","affiliations":[{"raw_affiliation_string":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]},{"raw_affiliation_string":"Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]},{"raw_affiliation_string":"School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5036163332"],"corresponding_institution_ids":["https://openalex.org/I165560825"],"apc_list":{"value":5230,"currency":"USD","value_usd":5230},"apc_paid":null,"fwci":2.0836,"has_fulltext":false,"cited_by_count":160,"citation_normalized_percentile":{"value":0.88870293,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"234","issue":"1","first_page":"223","last_page":"230"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.5145999789237976,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.5145999789237976,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.42500001192092896,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.028300000354647636,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/sglt2","display_name":"SGLT2","score":0.8840000033378601},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9850000143051147},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.8100000023841858},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.8009999990463257},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9290000200271606},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":1.0},{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":1.0},{"id":"https://openalex.org/keywords/anti-inflammatory-mechanism","display_name":"anti-inflammatory mechanism","score":0.7200000286102295},{"id":"https://openalex.org/keywords/pro-inflammatory-mediators","display_name":"pro-inflammatory mediators","score":0.9179999828338623},{"id":"https://openalex.org/keywords/molecular-pathways","display_name":"molecular pathways","score":0.5460000038146973},{"id":"https://openalex.org/keywords/glomerular-filtration-rate","display_name":"glomerular filtration rate","score":0.6899999976158142},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6100000143051147},{"id":"https://openalex.org/keywords/serum-uric-acid","display_name":"serum uric acid","score":0.968999981880188}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.831829309463501},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.7353338599205017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7054266333580017},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.6819857358932495},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6062765121459961},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.6061173677444458},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.5992421507835388},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5008606910705566},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.4993126392364502},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.4348861575126648},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.42881283164024353},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.42848700284957886},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4185158610343933},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4070656895637512},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3796508014202118},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.25684601068496704}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014527","descriptor_name":"Uric Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051297","descriptor_name":"Sodium-Glucose Transporter 2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051297","descriptor_name":"Sodium-Glucose Transporter 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/jcp.26851","doi":"https://doi.org/10.1002/jcp.26851","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jcp.26851","pdf_url":null,"source":{"id":"https://openalex.org/S43643205","display_name":"Journal of Cellular Physiology","issn_l":"0021-9541","issn":["0021-9541","1097-4652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cellular Physiology","raw_type":"journal-article"},{"id":"pmid:30076706","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30076706","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cellular physiology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W364216528","https://openalex.org/W805790533","https://openalex.org/W816311122","https://openalex.org/W1503352903","https://openalex.org/W1518103124","https://openalex.org/W1972849081","https://openalex.org/W1974864689","https://openalex.org/W1978804351","https://openalex.org/W1996854381","https://openalex.org/W2009204669","https://openalex.org/W2017066146","https://openalex.org/W2019181405","https://openalex.org/W2020133142","https://openalex.org/W2022638152","https://openalex.org/W2026672268","https://openalex.org/W2027545319","https://openalex.org/W2027990537","https://openalex.org/W2044316579","https://openalex.org/W2054361323","https://openalex.org/W2061172276","https://openalex.org/W2065586075","https://openalex.org/W2067850907","https://openalex.org/W2073587768","https://openalex.org/W2082049799","https://openalex.org/W2083341036","https://openalex.org/W2083485319","https://openalex.org/W2094156327","https://openalex.org/W2101344933","https://openalex.org/W2113507924","https://openalex.org/W2124502714","https://openalex.org/W2127883421","https://openalex.org/W2136487005","https://openalex.org/W2149185387","https://openalex.org/W2156587192","https://openalex.org/W2161311866","https://openalex.org/W2166852030","https://openalex.org/W2198148859","https://openalex.org/W2227867460","https://openalex.org/W2279086277","https://openalex.org/W2284028653","https://openalex.org/W2290648120","https://openalex.org/W2341429684","https://openalex.org/W2397061303","https://openalex.org/W2409181047","https://openalex.org/W2424539745","https://openalex.org/W2461230463","https://openalex.org/W2470481127","https://openalex.org/W2480909796","https://openalex.org/W2492672367","https://openalex.org/W2500767839","https://openalex.org/W2508112571","https://openalex.org/W2521173166","https://openalex.org/W2524330917","https://openalex.org/W2548675393","https://openalex.org/W2555252228","https://openalex.org/W2555543235","https://openalex.org/W2562563466","https://openalex.org/W2565719271","https://openalex.org/W2567051862","https://openalex.org/W2577056360","https://openalex.org/W2591873133","https://openalex.org/W2604133447","https://openalex.org/W2604677138","https://openalex.org/W2609755009","https://openalex.org/W2614462090","https://openalex.org/W2619744261","https://openalex.org/W2703544855","https://openalex.org/W2725253864","https://openalex.org/W2734312801","https://openalex.org/W2744696790","https://openalex.org/W2753603256","https://openalex.org/W2754298398","https://openalex.org/W2766579465","https://openalex.org/W2766622793","https://openalex.org/W2767726506","https://openalex.org/W2769721741","https://openalex.org/W2777514005","https://openalex.org/W2782612436","https://openalex.org/W2782992901","https://openalex.org/W2794052542"],"related_works":["https://openalex.org/W7167599397","https://openalex.org/W7128478795","https://openalex.org/W7125226189","https://openalex.org/W2914911240","https://openalex.org/W4400008853","https://openalex.org/W4385514532","https://openalex.org/W4413879520","https://openalex.org/W7167050895","https://openalex.org/W4392300909","https://openalex.org/W2892498615"],"abstract_inverted_index":{"Clinical":[0],"trials":[1],"with":[2],"sodium-glucose":[3],"cotransporter":[4],"2":[5],"(SGLT2)":[6],"inhibitors":[7,25,66,125],"(empagliflozin,":[8],"dapagliflozin,":[9],"and":[10,39,49,60,93],"canagliflozin)":[11],"have":[12],"shown":[13],"a":[14,27,82],"decrease":[15],"in":[16,76,85,129],"the":[17,51,86,103,112,130],"progression":[18],"of":[19,30,88,96,105,115],"chronic":[20],"kidney":[21],"disease":[22],"(CKD).":[23],"SGLT2":[24,65,116,124],"represent":[26],"new":[28],"category":[29],"oral":[31],"antidiabetic":[32],"agents":[33],"that":[34,64],"can":[35],"also":[36,133],"reduce":[37],"systolic":[38],"diastolic":[40],"blood":[41],"pressure,":[42],"as":[43,45,90],"well":[44],"serum":[46],"uric":[47],"acid,":[48],"improve":[50],"glomerular":[52],"filtration":[53],"rate.":[54],"Apart":[55],"from":[56],"affecting":[57],"renal":[58,77,97],"hemodynamics":[59],"glycotoxicity,":[61],"evidence":[62],"suggests":[63],"may":[67,126],"be":[68],"renoprotective":[69],"due":[70],"to":[71,102],"their":[72],"effects":[73],"on":[74],"inflammation":[75,128],"tissues.":[78],"Inflammatory":[79],"responses":[80],"play":[81],"prominent":[83],"role":[84],"pathophysiology":[87],"CKD":[89],"several":[91],"structural":[92],"functional":[94],"disorders":[95],"failure":[98],"are":[99,132],"strongly":[100],"related":[101],"overproduction":[104],"proinflammatory":[106],"mediators.":[107],"The":[108,118],"present":[109],"review":[110],"discusses":[111],"anti-inflammatory":[113],"properties":[114],"inhibitors.":[117],"different":[119],"molecular":[120],"pathways":[121],"through":[122],"which":[123],"affect":[127],"kidneys":[131],"commented":[134],"upon.":[135]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2886679183","counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":28},{"year":2022,"cited_by_count":33},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":19},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2018-08-22T00:00:00"}
